Get a Wegovy Prescription Online
Wegovy — injectable semaglutide 2.4 mg, once weekly — is FDA-approved for chronic weight management and produced about 15% average weight loss in its 68-week pivotal trial. A board-certified physician reviews your eligibility and writes your prescription the same day you qualify, all in one short telehealth visit. No clinic. Medication delivered in 24–48 hours.
Why patients choose WegovyPills.org for Wegovy
If you've researched Wegovy, you already know it works. The questions patients bring us are practical: how do I get the prescription, what does it actually cost, and who helps me during treatment? We answer all three at your first free consultation.
Same-day prescription
A board-certified physician reviews your eligibility, discusses your goals, and writes your Wegovy prescription the same day you qualify — one short telehealth visit, no clinic, no subscription lock-in.
7-day human support
Direct access to a dedicated care team every day of the week — dose escalation, progress reviews, medical and logistical questions. No chatbot loops; you reach a real person.
Clinically-backed results
The STEP 1 trial (1,961 adults) showed 14.9% average weight loss over 68 weeks, with about a third of participants losing 20% or more of their body weight.
Pay only when you order
No mandatory membership or subscription fees — you're not charged until you order. Refills stay online, and if needles are a barrier, Wegovy pills from $149/mo are an option your doctor can discuss.
Are you a candidate for Wegovy?
Most adults who qualify have one or more of the following:
- BMI of 30 or higher
- BMI of 27+ with hypertension, type 2 diabetes, high cholesterol, or sleep apnea
- Adult aged 18 or over
- No personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome
- Comfortable with once-weekly self-injection and reliable cold storage (36–46°F)
What is your primary goal for weight loss?
Wegovy is contraindicated with a personal or family history of MTC or MEN 2, and is not approved under 18. If needles or cold storage are a barrier, needle-free Wegovy pills (oral semaglutide, from $149/month) are an alternative worth discussing. Not sure if you qualify? Our physicians review your full history at the free consultation.
How much weight can you lose with Wegovy?
In the STEP 1 phase 3 trial (1,961 adults, 68 weeks), once-weekly Wegovy 2.4 mg produced a mean body-weight reduction of 14.9% versus 2.4% with placebo — and the SELECT trial (17,604 adults) showed a 20% relative reduction in major cardiovascular events in adults with obesity and established cardiovascular disease.
STEP 1 (Wilding et al., NEJM 2021) and SELECT (Lincoff et al., NEJM 2023), each alongside diet and activity changes. Individual results vary — weight loss depends on dose, adherence, diet, and activity. Your doctor sets realistic goals at the free consultation.
Wegovy Weight Loss Program
Starting price — free doctor consultation included in every plan, so you always know what you pay. Charged only after a board-certified doctor approves your prescription.
- No membership and no subscription, ever
- Self-pay pricing with no insurance required
- Brand-name Wegovy (semaglutide 2.4 mg weekly)
- Prescription based on a telehealth consultation
- Ongoing dose adjustments and refills online
- Delivered in 24–48 hours with tracking
Transparent self-pay pricing, no surprises
Brand-name Wegovy self-pay runs higher elsewhere — about $349/month at starter doses through manufacturer channels without insurance — and eligible commercially insured patients may pay less with the Novo Nordisk savings card. Many commercial plans cover Wegovy for BMI 30+, or 27+ with a qualifying condition; Medicare coverage varies.
- Our program: from $149/month, all-inclusive
- Your physician can help with prior authorization if you pursue insurance
- Dose-based pricing confirmed at your free consultation
- Needle-free alternative: Wegovy pills from $149/mo
- More: Wegovy & insurance guide
Switching, transferring, or already on Wegovy?
Thinking about switching to Wegovy?
On compounded semaglutide and want FDA-approved Wegovy? On Ozempic with a doctor recommending the weight-management formulation? Or on the injection and curious about the needle-free pill? Your physician reviews your current dose and guides the transition timing at the free consultation.
Transfer your care to us
If your current provider is hard to reach, slow with refills, or not built for telehealth, transferring is easy: your doctor reviews your current dose and any labs, then picks up where your previous provider left off. No gap in treatment, no restarting from scratch.
Already on Wegovy with questions?
Plateaued weight loss, early-week discomfort, medication interactions, or deciding whether to continue, switch, or pause — these are exactly what our doctors handle in a quick online check-in, with a clear plan at the end.
Wegovy vs other weight loss medications
How the weekly injection stacks up against the daily pill and the other major GLP-1 medications — and where to read the full head-to-heads.
| Medication | Mechanism | Dosing | Avg. trial weight loss | Route |
|---|---|---|---|---|
| Wegovy (semaglutide 2.4 mg) | GLP-1 agonist | Once weekly | 14.9% (68 wks) | Injection |
| Wegovy pills (oral semaglutide) | GLP-1 agonist | Once daily | About 14% (64 wks) | Oral |
| Zepbound (tirzepatide) | Dual GIP + GLP-1 | Once weekly | Up to 22.5% (72 wks) | Injection |
| Ozempic (semaglutide) | GLP-1 agonist | Once weekly | Varies by dose (diabetes dosing) | Injection |
Wegovy injection vs Wegovy pill
Same molecule, comparable studied results. The pill means no needles, no refrigeration, and daily dosing from $149/month — but requires an empty-stomach morning routine. The injection is once weekly with a larger long-term safety dataset. Full comparison: Wegovy pill vs Wegovy.
Wegovy vs Zepbound (tirzepatide)
Zepbound produced higher trial averages (up to 22.5% vs 14.9%); both are weekly injections. Wegovy has the longer real-world record — including the SELECT cardiovascular outcomes data — while Zepbound leads on raw percentage. Compare in depth: vs Zepbound or see our tirzepatide program.
Wegovy vs Ozempic
The same semaglutide at different doses and indications: Wegovy 2.4 mg is optimized for weight management, while Ozempic (up to 2 mg) is FDA-approved for type 2 diabetes. Details: vs Ozempic. Not sure which fits? Our doctors can help.
How to get Wegovy online in 3 steps
Book your free consultation
Pick a time that suits you — scheduling is open 24/7 with same-day slots. Booking takes about two minutes and costs nothing.
Meet a board-certified doctor
A short telehealth visit covers eligibility, your goals, and your health history. If Wegovy fits, your prescription is written the same day — typically within 10–15 minutes of approval.
Delivered in 24–48 hours
Wegovy pens arrive in discreet, tracked packaging with cold-chain handling. Dose escalation, refills, and check-ins continue online with 7-day support.
What patients say about Wegovy
Patients have shared their experiences with our weight loss programs — many highlighting real changes in health and habits.
This is honestly a game-changer. I've dropped 4 dress sizes, and I feel amazing.
I can't believe the results I've achieved. It's been four months, and I've already lost 15 pounds. I feel more confident in my own skin.
The results speak for themselves. I lost 20 pounds in just three months.
I've lost 27 pounds in five months. The medical guidance along with the medication helped me regain control over my eating habits and cravings.
After struggling with weight loss for years, I decided to try Wegovy. I've lost 55 pounds in six months, and I feel beyond thrilled.
Testimonials reflect individual experiences. Results vary and are not guaranteed — weight loss depends on dose, adherence, diet, and physical activity. Reviews are not a substitute for medical advice, and not everyone qualifies for treatment.
Frequently asked questions about Wegovy
Wegovy by state
See how the Wegovy program works where you live — every state has its own guide, with availability confirmed at booking.
Important Safety Information & Disclaimers
About treatment results
Individual results vary and are not guaranteed. Weight-loss figures on this page come from STEP 1, a 68-week randomized, double-blind, placebo-controlled trial of once-weekly semaglutide 2.4 mg in 1,961 adults (Wilding et al., New England Journal of Medicine, 2021); cardiovascular figures come from SELECT, a placebo-controlled outcomes trial in 17,604 adults with obesity and established cardiovascular disease (Lincoff et al., NEJM, 2023). Participants in both followed lifestyle interventions. Outcomes depend on dose, adherence, diet, activity, sex, baseline weight, and other conditions. Wegovy® should only be used under the supervision of a licensed healthcare provider.
Boxed warning and serious risks
Semaglutide carries a boxed warning: in rodent studies it caused thyroid C-cell tumors, and it is not known whether it causes medullary thyroid carcinoma (MTC) in humans. Do not use Wegovy® if you or a family member has a history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Other serious risks in prescribing information include pancreatitis, gallbladder disease, kidney injury, hypoglycemia with certain diabetes medications, diabetic retinopathy complications in patients with type 2 diabetes, severe allergic reactions, and mood changes — monitor for new or worsening depression or suicidal thoughts, contact your provider promptly if they occur, and in the U.S. call or text 988 in a mental-health emergency. Do not use during pregnancy or while breastfeeding, or after a prior serious allergic reaction to semaglutide. Common side effects include nausea, diarrhea, vomiting, constipation, and stomach discomfort, typically easing with gradual dose escalation.
Testimonials and comparisons
Testimonials reflect individual patient experiences and are not typical results, medical advice, or a guarantee of outcome. Cross-medication comparisons cite separate trials with different designs, durations, and populations — they are directional context, not head-to-head studies. Eligibility quiz results on this page are informational only and do not constitute a medical assessment.
Pricing, insurance, and availability
Program pricing reflects our platform only; third-party prices (including manufacturer channels and savings-card programs) change and are outside our control. Insurance and Medicare coverage vary by plan and state. Access to medications varies by location and pharmacy participation, and telehealth availability is confirmed at booking. WegovyPills.org is not responsible for third-party pricing, availability, or reimbursement policies.
Reporting side effects
Suspected adverse reactions can be reported to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
Scope of this page
This content is informational only and does not constitute medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider for personal medical decisions, and never start, stop, or change a medication based on a website alone.
Sources
- Wegovy® Prescribing Information — U.S. Food & Drug Administration
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — NEJM, 2021
- Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) — NEJM, 2023
- Postmarket Drug Safety Information — U.S. Food & Drug Administration
- Product Resources — Novo Nordisk A/S
Trademarks
Wegovy®, Ozempic®, Rybelsus®, Saxenda®, and Victoza® are registered trademarks of Novo Nordisk A/S. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. This website is independently operated and is not affiliated with, endorsed by, or sponsored by these companies; brand names are used for identification, education, and comparison only.
Ready to start your own weight loss journey?
Book your free consultation — same-day slots available. A board-certified doctor writes your Wegovy prescription the same day you qualify, with medication delivered in 24–48 hours. You're only charged after approval.
Book an Appointment